VGFC yields 3883.50% · PFE yields 6.20%● Live data
📍 VGFC pulled ahead of the other in Year 1
Combined, VGFC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VGFC + PFE for your $10,000?
The Very Good Food Company Inc., together with its subsidiaries, designs, develops, produces, distributes, and sells various plant-based cheese, meats, and other food alternatives. The company offers its products through its wholesale and e-commerce stores, and public markets, as well as the Butcher Shop & Restaurant under The Very Good Butchers brand. The company provides plant-based cheese brands comprising Bold Cheddah, a white cheddar style vegan cheese; Cheedah, a medium cheddar style vegan cheese; Dill'ish, a garlic and dill-havarti style vegan cheese; Goud AF, a smoky gouda style vegan cheese; and Pepper Jack, a monterey jack style vegan cheese. It also offers plant-based meat products comprising a line of sausages, steaks, burgers, and meatballs that is gluten-free, soy-free, and Non-GMO verified under Butcher's Select and The Very Good Butchers brands. The company distributes and sells its products in 10 provinces and three territories in Canada and 50 states in the United States through eCommerce, wholesale, and company owned butcher shops and restaurants operated under Victoria Flagship Store name located in Victoria, Canada. The company was formerly known as The Very Good Butchers Inc. and changed its name to The Very Good Food Company Inc. in October 2019. The Very Good Food Company Inc. was incorporated in 2016 and is headquartered in Vancouver, Canada.
Full VGFC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.